MATURE B-CELL NON-HODGKIN LYMPHOMA
Clinical trials for MATURE B-CELL NON-HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new MATURE B-CELL NON-HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for MATURE B-CELL NON-HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with Tough-to-Treat cancer
Disease control Recruiting nowThis study is testing a new drug called glofitamab, both by itself and combined with standard chemotherapy, in children and young adults whose aggressive B-cell lymphoma has come back or hasn't responded to prior treatment. The main goals are to see if the treatment is safe and i…
Matched conditions: MATURE B-CELL NON-HODGKIN LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
New hope for kids with Tough-to-Treat cancer: doubling down on a key drug
Disease control Recruiting nowThis study is testing if using a stronger chemotherapy schedule and giving a targeted drug called rituximab more often and earlier in treatment can help children and teenagers with very aggressive forms of B-cell lymphoma live longer without their cancer coming back. It builds on…
Matched conditions: MATURE B-CELL NON-HODGKIN LYMPHOMA
Phase: PHASE2, PHASE3 • Sponsor: Children's Cancer Group, China • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC